Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03092895
Recruitment Status : Active, not recruiting
First Posted : March 28, 2017
Last Update Posted : April 27, 2022
Information provided by (Responsible Party):
Jiangsu HengRui Medicine Co., Ltd.